ILRI news

Tom Randolph, an agricultural economist at ILRI, speaks with former ILRI project manager Oumar Diall while attending a 2006 workshop in Bamako, Mali, on controlling trypanosomosis drug resistance, a project he and Diall led for several years in West Africa (photo credit: ILRI/Stevie Mann).

Tom Randolph has been named director of a newly established CGIAR Research Program on Livestock and Fish. Jimmy Smith, new director general of the International Livestock Research Institute (ILRI), a position he took up on 1 October 2011, announced Randolph’s appointment on 13 October 2011.

ILRI leads this CGIAR research program, which is one of several new multi-institutional research programs initiated by the Consultative Group on International Agricultural Research (CGIAR). In this program, which aims to provide more meat, milk and fish by and for the poor, ILRI will be collaborating with other scientists and staff from three of its sister CGIAR centres—the International Center for Tropical Agriculture (CIAT), based in Cali, Colombia; the International Center for Agricultural Research in the Dry Areas (ICARDA), based in Aleppo, Syria; and the WorldFish Center, based in Penang, Malaysia. Many other strategic partners will play key roles in implementing the program in several ‘livestock value chains’ and countries targeted by the new project.

Randolph helped lead the collaborative processes employed over the last two years to develop the concept and subsequent full proposal for this research program.

Before this appointment, Randolph headed a team conducting research on smallholder competitiveness in changing markets under ILRI’s Market Opportunities Theme. His research interests and contributions at ILRI have been varied, including studies at the interface of animal and human health and assessments of the impacts of agricultural problems and the research conducted to address them, including evaluations of the impacts of tick and tick-borne diseases, animal health delivery systems, ILRI’s East Coast fever vaccine development research, the contributions economics and epidemiology can make to animal disease control and the control of bird flu in sub-Saharan Africa.

One of the projects Randolph led has helped to reduce parasite resistance to drugs used to control trypanosomosis (animal sleeping sickness) in the cotton belt of West Africa. This project established a clear picture of the distribution of potential resistance across a zone from eastern Guinea to western Burkina Faso, highlighting the importance of tsetse ecology, farming systems, accessibility to veterinary services and pharmaceutical products, and cattle breed in influencing drug use and misuse. Under Randolph’s leadership, this project evolved from a primary focus on the biological issue to a holistic understanding of the complex epidemiological and socioeconomic factors at farm, local, national and regional levels that influence the problem and determine the ability to address it.

Among his more recent projects is a groundbreaking assessment of the relations between dairy intensification, gender and child nutrition among smallholder farmers in the Rift Valley Province of Kenya; this project is investigating the pathways between dairy intensification and child nutrition.

An American from upstate New York, Randolph received an undergraduate degree in Chinese studies in 1976, after which he spent six years teaching English in Zaire with the Peace Corps. On his return to the United States, Randolph pursued an MSc and PhD in agricultural economics from Cornell University. His doctoral dissertation was based on field work he conducted in Malawi with the Harvard Institute for International Development, looking at the impact of agricultural commercialization on child nutrition in smallholder households. His thesis earned the American Agricultural Economics Association’s Outstanding PhD Dissertation Award. He subsequently joined the West African Rice Development Association (WARDA, now Africa Rice Centre), in Senegal, as a Rockefeller-funded post-doctoral fellow, later becoming policy economist and policy support program leader at WARDA’s Côte d’Ivoire headquarters.

Randolph joined ILRI in 1998 and will remain based at ILRI’s Nairobi, Kenya, headquarters as he directs this new multi-country and multi-institutional CGIAR Research Program on Livestock and Fish.

Share this post:

Hide Sites

Robert Zoellick, president of the World Bank (image on Flickr by International Monetary Fund).

Robert Zoellick, president of the World Bank, spoke today (6 July 2011) at the 40-year-anniversary celebrations of the Consultative Group on International Agricultural Research (CGIAR) at the World Bank in Washington, DC. His presentation followed a film about the historical beginnings of the CGIAR, including interviews of Norman Borlaug and Robert McNamara.

‘Both Norman Borlaug and Robert McNamara believed that it is possible to defeat hunger,’ Zoellick said. ‘They both worked to boost food production through science. And they both died within a few months of each other in 2009.’

Zoellick said that agriculture is a subject of strong personal interest for him; he grew up around farm families in the American midwest. And he said few things were as satisfying for him as speaking to farm families that had doubled, tripled or quadrupled their incomes through improved farm practices, which in turn rely on agricultural science.

Zoellick said that high food prices today are pushing 44 million people into poverty, and the global population is expected to reach 9 billion by 2050.

‘We’ll have to increase food production by 70% to feed everyone by mid-century,’ he said. ‘And we’ll have to do that with the rate of production increases dropping and in the face of climate change, which is predicted to decrease crop yields in Africa by 28%.’

Zoellick reported on some of the great achievements of the CGIAR over the last four decades. Among them, he cited the following work by the International Livestock Research Institute (ILRI) and its partners, including the Kenya Agricultural Research Institute.

There is now a vaccine for East Coast fever, which kills 1 cow every 30 seconds in 11 countries of Africa. The vaccine is expected to save more than a million cattle, with benefits worth up to USD270 million a year in the countries where the disease is now endemic.

‘I’ve been urging the G20 to put food first this year,’ said Zoellick. ‘One of my key messages at both G8 and G20 is the need to support agriculture and agricultural research.

“I see a 5-step challenge for the CGIAR,’ said Zoellick.
(1) Donor agencies increase funding to the CGIAR from USD670 million last year to USD1 billion by 2013.
(2) Donor agencies commit to multi-year predictable funding.
(3) Research institutions place greater focus on research to reduce post-harvest food losses (which can make up 20–50% of yields).
(4) Developing countries themselves increase their investments to agricultural research and development.
(5) Researchers and their supporters stand up for science and fight the current trend of cloaking ignorance in fashionable causes.

The moment is right to push the agricultural research agenda, Zoellick said. ‘The agricultural sector is fertile for innovation. And we can demonstrate the intimate links between this work and two of the big issues of our day—food security and climate change.’

Given the ammunition, he said, he’ll push this agenda forward.

Share this post:

Hide Sites

At the 79th General Session of the United Nations World Organisation for Animal Health (OIE), in Paris in May 2011, ILRI’s Jeff Mariner (second from right) stands among a group of distinguished people heading work responsible for the eradication of rinderpest, a status officially declared at this meeting (image credit: OIE).

Several world bodies are celebrating what is being described as ‘the greatest achievement in veterinary medicine’: the eradication of only the second disease from the face of the earth.

The disease is rinderpest, which means ‘cattle plague’ in German. It kills animals by a virus—and people by starving them through massive losses of their livestock.

‘In the nineteenth and twentieth centuries,’ reports the United Nations Food and Agriculture Organization (FAO), ‘the disease devastated parts of Africa, triggering extensive famines. . . . After decades of efforts to stamp out a disease that kept crossing national borders, countries and institutions agreed they needed to coordinate their efforts under a single, cohesive programme. In 1994, the Global Rinderpest Eradication Programme (GREP) was established at the UN Food and Agriculture Organization (FAO), in close association with the World Organization for Animal Health (OIE).

‘Excellent science, a massive vaccination effort, close international coordination and the commitment of people at all levels have helped make rinderpest eradication possible.

‘On June 28, 2011, FAO’s governing Conference will adopt a resolution officially declaring that rinderpest has been eradicated from animals worldwide. The successful fight against rinderpest underscores what can be achieved when communities, countries and institutions work together.’

Australian Peter Doherty, 1996 winner of the Nobel Prize for Medicine who served on the board of trustees of the International Laboratory for Research on Animal Diseases (ILRAD), a predecessor of  ILRI (photo credit: published on the Advance website).

Australian Peter Doherty, an immunologist who is the only veterinarian to win the Nobel Prize, for Physiology or Medicine, in 1996, and who served as chair of the board of trustees research program of the International Laboratory for Research on Animal Diseases (ILRAD), a predecessor of the International Livestock Research Institute (ILRI), is attending the FAO ceremonies this week. In an interview with FAO, he said:

Vaccine research is currently a very dynamic area of investigation and with sufficient investment and the enthusiastic participation of industry partners at the “downstream” end, we can achieve even better vaccines against many veterinary and human diseases.

The Washington Post in May reported that ‘the World Organization for Animal Health, at its annual meeting in Paris on Wednesday, accepted documentation from the last 14 countries that they were now free of rinderpest. The organization, which goes by its French acronym, OIE, was started in 1924 in response to a rinderpest importation in Europe.

‘The most recent recorded outbreak occurred in Kenya in 2001. Much of the past decade has been spent looking for new cases, in domesticated animals and in the wild, wandering herds of ungulates, or hoofed animals, in East Africa. The last place of especially intense surveillance was Somalia, where the final outbreak of smallpox occurred in 1977.

‘“There are a huge number of unsung heroes in lots of countries that made this possible,” said Michael Baron, a rinderpest virologist at the Institute for Animal Health in Surrey, England. “In most places, they were ordinary veterinary workers who were doing the vaccination, the surveillance, the teaching.”

‘Three things made rinderpest eradicable. Animals that survived infection became immune for life. A vaccine developed in the 1960s by Walter Plowright, an English scientist who died last year at 86, provided equally good immunity. And even though the virus could infect wild animals, it did not have a reservoir of host animals capable of carrying it for prolonged periods without becoming ill.

‘In 1994, the FAO launched an eradication program that was largely financed by European countries, although the United States, which never had rinderpest, also contributed money. The effort consisted of massive vaccination campaigns, which were made more practicable when two American researchers made a version of the Plowright vaccine that required no refrigeration. . . .’

One of those researchers was Jeffrey Mariner, now working at ILRI, in Nairobi, Kenya. Mariner also helped in surveillance work ‘with a technique called “participatory epidemiology” in which outside surveyors meet with herdsmen and ask open-ended questions about the health of their animals and when they last noticed certain symptoms.

‘“It was local knowledge that really helped us trace back the last places where transmission occurred—sitting down underneath a tree in the shade, listening to storytelling,” said Lubroth, of the FAO. . . .’

Read the whole article in the Washington Post, Rinderpest, or ‘cattle plague,’ becomes only second disease to be eradicated, 27 May 2011.

Read FAO’s interview of Peter Doherty: Healthier animals, healthier people, June 2011.

Share this post:

Hide Sites

Small-scale livestock-dependent agriculture in developing countries makes up one of three trajectories of global disease risk; here, cattle belonging to a widowed farmer in Garue, Mozambique, are brought in for the night by a herdsboy (photo credit: ILRI/Mann).

‘Current drivers and future directions of global livestock disease dynamics’ is a special feature published in the (online) 16 May 2011 issue of the Proceedings of the National Academy of Sciences (PNAS) of the USA. The authors of the paper are Brian Perry, Delia Grace and Keith Sones.

Irish veterinary epidemiologist Delia Grace leads a team researching animal health and food safety for trade at the International Livestock Research Institute (ILRI), based in Nairobi, Kenya.

In the PNAS paper, the authors write: ‘The current era of globalization is seeing unprecedented movements of people, products, capital and information. Although this has obvious implications for economies and ecosystems, globalization also affects the health of people and animals. This paper reviews changing patterns of livestock disease over the last two decades, discusses the drivers of these patterns, and plots future trajectories of livestock disease risk in an effort to capitalize on our understanding of the recent past and provide a guide to the uncertain future.’

While acknowledging the complexity of disease dynamics, the authors point to three main drivers of changing livestock disease dynamics: ecosystem change, ecosystem incursion, and movement of people and animals. Underlying these dynamics are the growing demand for livestock products (the Livestock Revolution) and increasing human population size.

The authors identify three trajectories of global disease dynamics:
‘(i) the worried well in developed countries (demanding less risk while broadening the circle of moral concern)
‘(ii) the intensifying and market-orientated systems of many developing countries, where highly complex disease patterns create hot spots for disease shifts
‘(iii) the neglected cold spots in poor countries, where rapid change in disease dynamics is less likely but smallholders and pastoralists continue to struggle with largely preventable and curable livestock diseases.’

On the topics of major trends in disease dynamics, the authors point out that ‘From a centuries-long and whole-world perspective, human wealth and health continue to improve, and animal health parallels this, showing an overall dramatic decline of infectious disease and shift to noncommunicable diseases. (This has been called the second epidemiological transition; the first epidemiological transition was 10,000 y ago, when human settlement led to a surge in zoonoses and crowd-related diseases.)’

However, the authors also say that ‘Although control and management of many endemic diseases in rich countries have improved, new diseases such as BSE and HPAI have emerged. Some consider that we face a third epidemiological transition of disastrous consequence in which globalization and ecological disruption drive disease emergence and reemergence; as occurred in the first epidemiological transition (associated with neolithic sedentarization and the domestication of livestock), the worst of the emerging diseases are likely to be zoonotic.’

The authors go on to consider ‘the drivers with greatest influence on livestock disease dynamics, namely increasing human population size and prosperity and the related demand-driven Livestock Revolution. . . . [W]e identify three overarching sets of animal diseases dynamics and associated control. Each system is facing different risks to livestock health, each has different determinants of disease status and capacity to respond, and each requires different approaches to resolve them.’

‘In the background,’ they say, ‘is the significant component of the world’s livestock enterprises in the hands of the very poor, for whom intensification is just not a realistic option and who are likely to be most vulnerable to disease resurgence. . . .

‘Although we call these [very poor livestock] systems cold spots for disease dynamics and emergence, they are inevitably hot spots for endemic diseases, periodic epidemics (such as Newcastle disease, which regularly wipes out village flocks), and neglected zoonoses, which significantly impact on human health. Because of the low densities of livestock, their remoteness, and the slow change in husbandry practices, these are probably not hot spots for emerging diseases. . . .

‘This review is prognostic rather than therapeutic, presenting implications for livestock disease in the 21st century. In an increasingly globalized world, deepening of the existing balkanization of livestock health status will create inevitable instability. The main challenges are (i) to speed the convergence of livestock health between the intensifying and intensified regions through improved coordination, communication, and harmonization and (ii ) to improve resilience of smallholder livestock systems, including the support of viable exits from livestock keeping.’

Read the whole paper in the Proceedings of the National Academy of Sciences: Current drivers and future directions of global livestock disease dynamics, by Brian Perry, Delia Grace and Keith Sones, 16 May 2011.

Read an ILRI brief: Why animals matter to health and nutrition, February 2011.

Read another ILRI News Blog article related to this topic: Adapting agriculture to improve human health—New ILRI policy brief, 21 February 2011.

Read an ILRI news release: Livestock boom risks aggravating animal ‘plagues,’ poses growing threat to food security and health of the world’s poor, 2 February 2011.

Share this post:

Hide Sites

Cow suffering from trypanosomiasis (photo credit: ILRI/Elsworth).

An international research team using a new combination of approaches has found two genes that may prove of vital importance to the lives and livelihoods of millions of farmers in a tsetse fly-plagued swathe of Africa the size of the United States. The team’s results were published today in the Proceedings of the National Academy of Sciences (PNAS).

The research, aimed at finding the biological keys to protection from a single-celled trypanosome parasite that causes both African sleeping sickness in people and a wasting disease in cattle, brought together a range of high-tech tools and field observations to address a critical affliction of some of the world’s poorest people.

With increased surveillance and control, sleeping sickness infections in people have dropped ten-fold in the last 13 years, from an estimated 300,000 cases a year in 1998 to some 30,000 in 2009, with the disease eventually killing more than half of those infected. Although best known for causing human sleeping sickness, the trypanosome parasite’s most devastating blow to human welfare comes in an animal form, with sick, unproductive cattle costing mixed crop-livestock farmers and livestock herders huge losses and opportunities. The annual economic impact of ‘nagana,’ a common name in Africa for the form of the disease that affects cattle (officially known as African animal trypanosomiasis), has been estimated at US$4–5 billion.

In a vast tsetse belt across Africa, stretching from Senegal on the west coast to Tanzania on the east coast, and from Chad in the north to Zimbabwe in the south, the disease each year renders millions of cattle too weak to plow land or to haul loads, and too sickly to give milk or to breed, before finally killing off most of those infected. This means that in much of Africa, where tractors and commercial fertilizers are scarce and prohibitively expensive, cattle are largely unavailable for tilling and fertilizing croplands or for producing milk and meat for families. The tsetse fly and the disease it transmits are thus responsible for millions of farmers having to till their croplands by hand rather than by animal-drawn plow.

‘The two genes discovered in this research could provide a way for cattle breeders to identify the animals that are best at resisting disease when infected with trypanosome parasites, which are transmitted to animals and people by the bite of infected tsetse flies,’ said senior author Steve Kemp, a geneticist on joint appointment with the Nairobi-based International Livestock Research Institute (ILRI) and the University of Liverpool.

This genetics of disease resistance research was led by scientists from ILRI in Africa and from the UK universities of Liverpool, Manchester and Edinburgh, and involved researchers from other institutions in Britain, Ireland and South Korea.

The researchers drew on the fact that while the humped cattle breeds characteristic of much of Africa are susceptible to disease-causing trypanosome parasites, a humpless West African breed, called the N’Dama, is not seriously affected by the disease. Having been domesticated in Africa some 8,000 or more years ago, this most ancient of African breeds has had time to evolve resistance to the parasites. This makes the N’Dama a valued animal in Africa’s endemic regions. On the other hand, N’Dama cattle tend to be smaller, to produce less milk, and to be less docile than their bigger, humped cousins.

African agriculturalists of all kinds would like to see the N’Dama’s inherent disease resistance transferred to these other more productive breeds, but this is difficult without precise knowledge of the genes responsible for disease resistance in the N’Dama. Finding these genes has been the ‘Holy Grail’ of a group of international livestock geneticists for more than two decades, but the genetic and other biological pathways that control bovine disease resistance are complex and have proven difficult to determine.

The PNAS paper is thus a landmark piece of research in this field. The international and inter-institutional team that made this breakthrough did so by combining a range of genetic approaches, which until now have largely been used separately.

‘This may be the first example of scientists bringing together different ways of getting to the bottom of the genetics of a very complex trait,’ said Kemp. ‘Combined, the data were like a Venn diagram overlaying different sets of evidence. It was the overlap that interested us.’

They used these genetic approaches to distinguish differences between the ‘trypano-tolerant’ (humpless) N’Dama, which come from West Africa, and ‘trypano-susceptible’ (humped) Boran cattle, which come from Kenya, in East Africa. The scientists first identified the broad regions of their genomes controlling their different responses to infection with trypanosome parasites, but this was insufficient to identify the specific genes controlling resistance to the disease. So the scientists began adding layers of information obtained from other approaches. They sequenced genes from these regions to look for differences in those sequences between the two breeds.

The team at Edinburgh conducted gene expression analyses to investigate any differences in genetic activity in the tissues of the two cattle breeds after sets of animals of both breeds were experimentally infected with the parasites. Then, the ILRI group tested selected genes in the lab. Finally, they looked at the genetics of cattle populations from all over Africa.

Analyzing the vast datasets created in this research presented significant computational challenges. Andy Brass and his team in the School of Computer Science at the University of Manchester managed to capture, integrate and analyze the highly complex set of biological data by using workflow software called ‘Taverna,’ which was developed as part of a UK e-Science initiative by Manchester computer scientist Carole Goble and her ‘myGrid’ team.

‘The Taverna workflows we developed are capable of analyzing huge amounts of biological data quickly and accurately,’ said Brass. ‘Taverna’s infrastructure enabled us to develop the systematic analysis pipelines we required and to rapidly evolve the analysis as new data came into the project. We’re sharing these workflows so they can be re-used by other researchers looking at different disease models. This breakthrough demonstrates the real-life benefits of computer science and how a problem costing many lives can be tackled using pioneering E-Science systems.’

To bolster the findings, population geneticists from ILRI and the University of Dublin examined bovine genetic sequences for clues about the history of the different breeds. Their evidence confirmed that the two genes identified by the ILRI-Liverpool-Manchester groups were likely to have evolved in response to the presence of trypanosome parasites.

‘We believe the reason the N’Dama do not fall sick when infected with trypanosome parasites is that these animals, unlike others, have evolved ways to control the infection without mounting a runaway immune response that ends up damaging them,’ said lead author Harry Noyes, of the University of Liverpool. ‘Many human infections trigger similarly self-destructive immune responses, and our observations may point to ways of reducing such damage in people as well as livestock.’

This paper, said Kemp, in addition to advancing our understanding of the cascade of genes that allow Africa’s N’Dama cattle to fight animal trypanosomiasis, reaffirms the importance of maintaining as many of Africa’s indigenous animal breeds (as well as plant/crop varieties) as possible. The N’Dama’s disease resistance to trypanosome parasites is an example of a genetic trait that, while not yet fully understood, is clearly of vital importance to the continent’s future food security. But the continued existence of the N’Dama, like that of other native ‘niche’ African livestock breeds, remains under threat.

With this new knowledge of the genes controlling resistance to trypanosomiasis in the N’Dama, breeders could screen African cattle to identify animals with relatively high levels of disease resistance and furthermore incorporate the genetic markers for disease resistance with markers for other important traits, such as high productivity and drought tolerance, for improved breeding programs generally.

If further research confirms the significance of these genes in disease resistance, a conventional breeding program could develop a small breeding herd of disease-resistant cattle in 10–15 years, which could then be used over the next several decades to populate Africa’s different regions with animals most suited to those regions. Using genetic engineering techniques to achieve the same disease-resistant breeding herd, an approach still in its early days, could perhaps be done in four or five years, Kemp said. Once again, it would be several decades before such disease-resistant animals could be made available to most smallholder farmers and herders on the continent.

‘So it’s time we got started,’ said Kemp.

###

See this news and related background material at ILRI’s online press room.

The International Livestock Research Institute (www.ilri.org) works with partners worldwide to help poor people keep their farm animals alive and productive, increase and sustain their livestock and farm productivity, and find profitable markets for their animal products. ILRI’s headquarters are in Nairobi, Kenya; we have a principal campus in Addis Ababa, Ethiopia, and 13 offices in other regions of Africa and Asia. ILRI is part of the Consultative Group on International Agricultural Research (www.cgiar.org), which works to reduce hunger, poverty, illness and environmental degradation in developing countries by generating and sharing relevant agricultural knowledge, technologies and policies. This research is focused on development, conducted by a Consortium (http://consortium.cgiar.org) of 15 CGIAR centres working with hundreds of partners worldwide, and supported by a multi-donor Fund (www.cgiarfund.org).

The University of Liverpool (www.liv.ac.uk) is a member of the Russell Group of leading research-intensive institutions in the UK. It attracts collaborative and contract research commissions from a wide range of national and international organizations valued at more than £110 million annually.

The University of Manchester (www.manchester.ac.uk), also a member of the Russell Group, is the largest single-site university in the UK. It has 22 academic schools and hundreds of specialist research groups undertaking pioneering multi-disciplinary teaching and research of worldwide significance. According to the results of the 2008 Research Assessment Exercise, the University of Manchester is now one of the country’s major research universities, rated third in the UK in terms of ‘research power’. The university has an annual income of £684 million and attracted £253 million in external research funding in 2007/08.

Share this post:

Hide Sites

ILRI biotechnology director Vish Nene (left) and new ILRI board member Lorne Babiuk (right) at the November 2010 meeting of the ILRI Board of Trustees (photo credit: ILRI/MacMillan).

Lorne Babiuk, a leader in Canadian vaccine research and vice-president for research at the University of Alberta, Canada, joined the board of trustees of the International Livestock Research Institute (ILRI) this month (November 2010), when he attended his first board meeting, held at ILRI’s headquarters, in Nairobi, Kenya.

As vice-president of research, Babiuk facilitates the University of Alberta’s research, builds research consortia and strengthens the university’s international research links and collaborations. In 2010, the university opened the Li Ka Shing Institute of Virology, an institute created through a combined gift of $25-million from the Li Ka Shing (Canada) Foundation and $52.5-million from the Government of Alberta. The donation—the largest cash gift in the university’s history—will provide a state-of-the-art home to some of the world’s very best researchers in virus-based diseases. The new institute is working to attract significant private-sector collaboration with multinational pharmaceutical and life sciences companies.

Since 2005, Babiuk has also served as principal investigator on a grant from the Bill and Melinda Gates ‘Grand Challenge in Global Health’ program, in which he and his team are developing vaccines against whooping cough (pertussis) in infants and young children, to be delivered in a single dose, without use of a needle. Children now need five doses of the vaccine to be fully protected and few children in the developing world get all the boosters.

Babiuk also supports Albertan research initiatives such as the Pan Albertan Neuroscience Network. As vice-president, he established an annual event that celebrates the breadth and depth of the university’s research in all disciplines—from social sciences to the arts, humanities, medical, agricultural, natural sciences and engineering. He has consistently fostered research that crosses traditional disciplinary boundaries by, for example, supporting collaborations between social scientists and medical, agricultural and engineering researchers. And he helped develop the infrastructure needed by researchers in all fields to be more successful in individual and team grants.

Before moving to the University of Alberta, Babiuk built up a research institute—the Vaccine and Infectious Disease Organization (VIDO), at the University of Saskatchewan—which became internationally recognized as a leader in new vaccine development. In 2005, he completed a US$19.4 million expansion of VIDO, and just before leaving VIDO, he assembled the funding needed to build a $140-million level-three bio-containment facility for work on infectious diseases.

Earlier in his career, Babiuk was part of a research consortium that developed and began testing a vaccine for SARS (sever acute respiratory syndrome) within 18 months of its outbreak in Canada. In addition to SARS and whooping cough, Babiuk has led research into the herpes virus and the respiratory syncitial virus and created a vaccine against rotavirus in calves, which allowed researchers later to develop a vaccine for rotavirus in children.

After completing a master’s degree in soil microbiology, Babiuk earned a PhD in virology from the University of British Columbia and a DSc from the University of Saskatchewan’s Department of Veterinary Microbiology. He has mentored over 90 graduate students and postdoctoral fellows and published over 500 peer-reviewed manuscripts and 100 book chapters or reviews. He holds 28 issued patents and has 18 patents pending.

Share this post:

Hide Sites

Tom Olaka, a community animal health worker in Karamajong, northern Uganda, was part of a vaccination campaign in remote areas of the Horn of Africa that drove the cattle plague rinderpest to extinction in 2010 (photo credit: Christine Jost).

A superb example of why technical breakthroughs matter is reported in the current issue (22 October 2010) of the leading science journal, Science.

The eradication of rinderpest from the face of the earth, probably the most remarkable achievement in the history of veterinary science, is a milestone expected to be announced in mid-2011 pending a review of final official disease status reports from a handful of countries to the World Organisation for Animal Health.

A plague of cattle and wild ungulates, rinderpest would not have been eradicated without such a technical breakthrough. This was the development of an improved vaccine that did not require a 'cold chain' and thus could be administered in some of the most inhospitable regions in the Horn of Africa, where the virus was able to persist due to lack of vaccination campaigns in these hotspots.

Rinderpest is a viral livestock disease that has afflicted Europe, Asia and Africa for centuries. It killed more than 90 per cent of the domesticated animals, as well as untold numbers of people and plains game, in Africa at the turn of the 19th century, a devastation so complete that its impacts are still felt today, more than a century later. The last-known outbreak of rinderpest occurred in Kenya in 2001.

The key technical breakthrough in this effort involved development of an improved vaccine against rinderpest. The original vaccine was developed at the Kenya Agricultural Research Institute (KARI) laboratories. In 1990, Jeffrey Mariner, a veterinary epidemiologist who at that time was at the Tufts Cummings School of Veterinary Medicine and working with the Africa Union-Inter-African Bureau for Animal Resources (AU-IBAR), improved the vaccine by producing a thermostable version that did not require refrigeration up to the point of use. This allowed vets and technicians to backpack the vaccine into remote war-torn areas, where vet services had broken down and international agencies dared not send personnel. The AU-IBAR led the Pan-African Rinderpest Campaign, which coordinated the efforts that resulted in the eventual eradication of rinderpest from Africa.

Now working in the Nairobi laboratories of at the International Livestock Research Institute (ILRI), Mariner says that just as important as this technological advance was getting the development community to begin to address how people work together. Mariner and his colleagues at AU-IBAR themselves took three innovations as lessons from the rinderpest eradication campaign: (1) community-based vaccination programs, (2) participatory surveillance systems based on local knowledge, and (3) optimized control strategies that target high-risk communities through.

‘We must examine issues from the perspective of each group of stakeholders involved and visualize how proposed changes would affect them,’ says Mariner. ‘The power relationships of the groups also need to be considered. Advocates for change must then craft a new vision for how the various stakeholder groups will function that is sufficiently exciting to get people to risk change.’

Excerpts from the Science article, by Dennis Normille, follow.
'Rinderpest, an infectious disease that has decimated cattle and devastated their keepers for millennia, is gone. The United Nations Food and Agriculture Organization (FAO) announced on 14 October in Rome that a 16-year eradication effort has succeeded and fieldwork has ended.

'“This is the first time that an animal disease is being eradicated in the world and the second disease in human history after smallpox,” FAO Director-General Jacques Diouf said in his World Food Day address in Rome the next day.

'“It is probably the most remarkable achievement in the history of veterinary science,” says Peter Roeder, a British veterinarian involved with FAO’s Global Rinderpest Eradication Programme (GREP) from its launch in 1994 until he retired in 2007. For the veterinarians who participated in the effort, the achievement is particularly poignant. . . .

'One formality remains: The Paris-based World Organisation for Animal Health (OIE) still must complete the certification of a handful of countries as rinderpest free. OIE is likely to adopt an official declaration recognizing the demise of the disease at its May assembly. Meanwhile, animal-disease fighters have already been applying lessons learned from the rinderpest campaign and pondering which animal disease might be the next target for eradication.

'Although nearly forgotten in much of the West, as recently as the early 1900s, outbreaks of rinderpest—from the German for “cattle plague”—regularly ravaged cattle herds across Eurasia, often claiming one-third of the calves in any herd. The virus, a relative of those that cause canine distemper and human measles, spreads through exhaled droplets and feces of sick animals, causing fever, diarrhea, dehydration, and death in a matter of days. It primarily affects young animals; those that survive an infection are immune for life.

'When the virus hit previously unexposed herds, the impact was horrific. In less than a decade after the virus was inadvertently introduced to the horn of Africa in 1889, it spread throughout sub-Saharan Africa, killing 90% of the cattle and a large proportion of domestic oxen used for plowing and decimating wild buffalo, giraffe, and wildebeest populations. With herding, farming, and hunting devastated, famine claimed an estimated one-third of the population of Ethiopia and two-thirds of the Maasai people of Kenya and Tanzania. . . .

'In 1994, when rinderpest was entrenched in central Africa, the Arabian Peninsula, and a swath stretching from Turkey through India and to Sri Lanka, FAO brought together three regional rinderpest-control programs into GREP and set the goal of eliminating the disease by 2010. . . .

'The key technical breakthrough was the recognition that the virus was re-emerging from just a handful of reservoirs that could be the targets of intensive surveillance and vaccination campaigns. In 1990, Jeffrey Mariner, then at Tufts University School of Veterinary Medicine (now the Cummings School of Veterinary Medicine), had developed an improved vaccine that did not require refrigeration up to the point of use. This allowed vets and technicians to backpack vaccine into remote areas. One of the reservoirs was in the heart of war-torn eastern Africa, where vet services had broken down and international agencies dared not send personnel. GREP relied on local pastoralists to track the disease and on trained community animal health workers to administer the vaccine to quell outbreaks.

'. . . The virus was last detected in 2001 in wild buffaloes in Meru National Park in Kenya, on the edge of the Somali ecosystem.

'What comes next? Some veterinary experts question whether the international community is ready to take on another massive eradication campaign, but one disease mentioned as a possible eradication target is peste des petites ruminants (PPR), which is highly contagious and lethal among sheep and goats. Related to the rinderpest virus, the PPR virus has long circulated in central Africa, the Middle East, and the Indian subcontinent and has recently spread to Morocco. . . .'

ILRI's Jeff Mariner is now working on an improved vaccine for this disease.

—-

Read the whole article at Science (registration needed to read the full article): Rinderpest, deadly for cattle, joins smallpox as a vanquished disease, 22 October 2010.

To find out what the eradication of rinderpest means for livestock farmers around the world, listen to the following interview featuring John McDermott, ILRI's deputy director general.

Share this post:

Hide Sites

East Coast fever is a major livestock disease in eastern, central and southern Africa. Transmitted by ticks infected with a protozoan parasite (Theileria  parva), it kills over 1 million animals each year, damaging livelihoods of poor livestock keepers and farmers in 11 countries. Researchers from organizations such as the International Livestock Research Institute (ILRI) are working to find innovative ways to protect African livestock against this and other ‘orphan’ livestock diseases.

One of the successes in the efforts to fight East Coast fever has been the development of a ‘live’ vaccine, which includes the whole parasite, weakened so as not to cause severe disease thatcame after over 30 years of research by organizations including ILRI and the Kenya Agricultural Research Institute. This long-term research was funded by UK Department for International Development and other donors of the Consultative Group on International Agricultural Research. The vaccine is now registered in Kenya, Malawi and Tanzania and its widespread use is being promoted so that it can give protection to the animals on which many poor people in these countries depend.

In the following audio interview, John McDermott, Deputy Director General-Research at ILRI, speaks in Nairobi of the need ‘to develop networks that can distribute and deliver’ the vaccine to those who need it, which should encourage its widespread use. This interview, produced in July 2010 by AFGAX Radio (http://www.agfax.net), also shares the expectations of a veterinarian from Kenya and a farmer from Tanzania of how the vaccine will help livestock keepers.

To listen to the interview, visit: http://www.agfax.net/radio/detail.php?i=353

More information about the East Coast fever live vaccine is available in the following article.

Share this post:

Hide Sites

A vaccine is being made available to save the lives of a million cattle in sub-Saharan Africa against a lethal disease and to help safeguard the livelihoods of people who rely on their cattle for their survival.

East Coast fever is a tick-transmitted disease that kills one cow every 30 seconds. It puts the lives of more than 25 million cattle at risk in the 11 countries of sub-Saharan Africa where the disease is now endemic. The disease endangers a further 10 million animals in regions such as southern Sudan, where it has been spreading at a rate of more than 30 kilometres a year. While decimating herds of indigenous cattle, East Coast fever is an even greater threat to improved exotic cattle breeds and is therefore limiting the development of livestock enterprises, particularly dairy, which often depend on higher milk-yielding crossbred cattle. The vaccine could save the affected countries at least a quarter of a million US dollars a year.

Registration of the East Coast fever vaccine is central to its safety and efficacy and to ensuring its sustainable supply through its commercialization. The East Coast fever vaccine has been registered in Tanzania for the first time, a major milestone that will be recognized at a launch event in Arusha, northern Tanzania, on May 20. Recognizing the importance of this development for the millions whose cattle are at risk from the disease, governments, regulators, livestock producers, scientists, veterinarians, intellectual property experts, vaccine distributors and delivery agents as well as livestock keepers – all links in a chain involved in getting the vaccine from laboratory bench into the animal – will be represented.

An experimental vaccine against East Coast fever was first developed more than 30 years ago at the Kenyan Agricultural Research Institute (KARI). Major funding from the UK Government’s Department for International Development (DFID) and others enabled work to produce the vaccine on a larger scale. When stocks from 1990s ran low, the Africa Union/Interafrican Bureau for Animal Resources and chief veterinary officers in the affected countries asked the International Livestock Research Institute (ILRI) to produce more and ILRI subsequently produced a million doses of the vaccine to fill this gap. But the full potential for livestock keepers to benefit from the vaccine will only be achieved through longer term solutions for the sustainable production, distribution and delivery of the vaccine.

With $28US million provided by the Bill & Melinda Gates Foundation and DFID, a not-for-profit organization called GALVmed (Global Alliance for Livestock Veterinary Medicines) is fostering innovative commercial means for the registration, commercial distribution and delivery of this new batch of the vaccine. A focus on sustainability underpins GALVmed’s approach and the Global Alliance is bringing public and private partners together to ensure that the vaccine is available to those who need it most.

Previous control of East Coast fever relied on use of acaracide dips and sprays, but these have several drawbacks. Ticks can develop resistance to acaracides and regular acaricide use can generate health, safety and environmental concerns. Furthermore, dipping facilities are often not operational in remote areas.

This effective East Coast fever vaccine uses an ‘infection-and-treatment method’, so-called because the animals are infected with whole parasites while being treated with antibiotics to stop development of disease. Animals need to be immunized only once in their lives, and calves, which are particularly susceptible to the disease, can be immunized as early as 1 month of age.

Over the past several years, the field logistics involved in mass vaccinations of cattle with the infection-and-treatment method have been greatly improved, due largely to the work of a private company, VetAgro Tanzania Ltd, which has been working with Maasai cattle herders in northern Tanzania. VetAgro has vaccinated more than 500,000 Tanzanian animals against East Coast fever since 1998, with more than 95% of these vaccinations carried out in remote pastoral areas. This vaccination campaign has reduced calf mortality in herds by 95%. In the smallholder dairy sector, vaccination reduced the incidence of East Coast fever by 98%. In addition, most smallholder dairy farmers reduced their acaracide use by at least 75%, which reduced both their financial and environmental costs.

Notes for Editors

What is East Coast fever?
East Coast fever is caused by Theleria parva (an intracellular protozoan parasite), which is transmitted by the brown ear tick Rhipicephalus appendiculatus. The parasites the tick carries make cattle sick, inducing high fever and lympho-proliferative syndrome, usually killing the animals within three weeks of their infection.

East Coast fever was introduced to southern Africa at the beginning of the twentieth century with cattle imported from eastern Africa, where the disease had been endemic for centuries. This introduction caused dramatic cattle losses. The disease since then has persisted in 11 countries in eastern, central and southern Africa – Burundi, Democratic Republic of Congo, Kenya, Malawi, Mozambique, Rwanda, Sudan, Tanzania, Uganda, Zambia and Zimbabwe. The disease devastates the livelihoods of small-scale mixed crop-and-livestock farmers, particularly smallholder and emerging dairy producers, as well as pastoral livestock herders, such as the Maasai in East Africa.

The infection-and-treatment immunization method against East Coast fever was developed by research conducted over three decades by the East African Community and the Kenya Agricultural Research Institute (KARI) at Muguga, Kenya (www.kari.org). Researchers at the International Livestock Research Institute (ILRI), in Nairobi, Kenya (www.ilri.org), helped to refine the live vaccine. This long-term research was funded by the UK Department for International Development (DFID) (www.dfid.gov.uk) and other donors of the Consultative Group on International Agricultural Research (CGIAR) (www.cgiar.org).

The first bulk batch of the vaccine, produced by ILRI 15 years ago, has protected one million animals against East coast fever, with the survival of these animals raising the standards of living for many livestock keepers and their families. Field trials of the new vaccine batch, also produced at ILRI, were completed in accordance with international standards to ensure that it is safe and effective.

How is the vaccine stored and administered?
Straws of the East Coast fever vaccine are stored in liquid nitrogen until needed, with the final preparation made either in an office or in the field. The vaccine must be used within six hours of its reconstitution, with any doses not used discarded. Vaccination is always carried out by trained veterinary personnel working in collaboration with livestock keepers. Only healthy animals are presented for vaccination; a dosage of 30% oxytetracycline antibiotic is injected into an animal’s muscle while the vaccine is injected near the animal’s ear. Every animal vaccinated is given an eartag, the presence of which subsequently increases the market value the animal. Young calves are given a worm treatment to avoid worms interfering with the immunization process.

Note
Case studies illustrating the impact of the infection-and-treatment vaccine on people’s lives are available on the GALVmed website at: www.galvmed.org/path-to-progress
For more information about the GALVmed launch of the live vaccine, on 20 May 2010, in Arusha, Tanzania, go to www.galvmed.org/

Share this post:

Hide Sites

The National Science Foundation (NSF) of the United States announced on 12 May 2010 that the Foundation, in partnership with the Bill & Melinda Gates Foundation, is awarding 15 grants worth US$20 million in support of basic research for generating sustainable solutions to big agricultural problems in developing countries.

These are the first grants in a new five-year Basic Research to Enable Agricultural Development (BREAD) program, which is jointly funded by NSF and the Gates Foundation.

The awards in this first year of funding will allow leading scientists worldwide to work together in basic research testing novel and creative approaches to reducing longstanding problems faced by smallholder farmers in poor countries.

Scientists from the Nairobi, Kenya, animal health laboratories of the International Livestock Research Institute (ILRI) will participate in 2 of the 15 projects selected among the many submitted to BREAD for funding.

Biologists at New York and Michigan State universities and Regeneron Pharmaceuticals (USA), the Roslin Institute and the University of Edinburgh (UK) and ILRI (Kenya) will test a novel approach to developing cattle that are resistant to trypanosomosis, a deadly cattle disease that is closely related to sleeping sickness in humans and that holds back animal agriculture across a swath of Africa as large as continental USA.

In another project, scientists from the University of Vermont and Plum Island Animal Disease Center (USA) will work with the University of Copenhagen (Denmark) and ILRI on use of advanced genetics to develop vaccines for East Coast fever and other cattle diseases that threaten the livelihoods of millions of smallholder farmers in sub-Saharan Africa.

Go here for a 12 May 2010 news release from the US National Science Foundation: http://www.nsf.gov/news/news_summ.jsp?cntn_id=116932

A complete list of 2010 BREAD awards can be accessed at: http://www.nsf.gov/bio/pubs/awards/bread10.htm

Share this post:

Hide Sites